CompletedNCT07173439
Multi-center, Single Blinded, RCT, Pivotal Study to Evaluate the Efficacy and Safety of DTx to Improve ADHD
Device studyAges 6–12South Korea
Understand this study
Who was this study for?
Listed age limits: 6 years to 12 years.
- Listed locations
- SeoulSee all locations and recruitment
Study information
Study start dateStarted: April 15, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 120
- Sponsor
- EMOTIV
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- Device
- Locations
- South Korea
- Age range
- From 6 Years to 12 Years
- Official registry ID
- NCT07173439
- Official title
Show the full official title
A Multi-center, Prospective, Single Blinded, Randomized, Comparative, Pivotal Clinical Trial to Evaluate the Efficacy and Safety of Digital Therapeutics to Improve ADHD Symptoms of Patients Diagnosed With ADHD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Seoul
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is EMOTIV.
Who was this study for?
Listed age limits: 6 years to 12 years.
